Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
PHASE2
Standard treatment for locally advanced gastric cancer currently involves s...
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
PHASE2
This clinical trial studies whether measuring circulating tumor deoxyribonu...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium